Opportunity Information: Apply for 611 2009 02 RFI MODIFICATION 01
Apply for 611 2009 02 RFI MODIFICATION 01
- The Zambia USAID Lusaka in the health sector is offering a public funding opportunity titled "Future Competitive Procurement for Community Based Prevention Initiative for Orphans and Vulnerable Children (OVC), Youth, and other Vulnerable Populations Program in Zambia" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 98.001 USAID Foreign Assistance for Programs Overseas.
- This funding opportunity was created on Sep 21, 2009 and posted on Jun 7, 2009.
- Applicants must submit their applications by Jun 19, 2009. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $60,000,000.00 in funding.
- The number of recipients for this funding is limited to 2 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This posting is an informational notice from USAID/Zambia, not an active Request for Applications. USAID is circulating a draft Concept Paper for a planned Community Based Prevention Initiative focused on orphans and vulnerable children (OVC), youth, and other vulnerable populations in Zambia, and is asking organizations and other interested parties to submit comments and suggestions. The intent is to use stakeholder feedback to improve the quality of the final funding solicitation before it is released.
The proposed program is positioned within U.S. Government global health priorities and is explicitly guided by the Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008, along with technical guidance from the Office of the Global AIDS Coordinator (OGAC). In practical terms, that framing signals that the eventual program will likely align with PEPFAR-related prevention and vulnerability-reduction objectives, and that applicants should expect requirements consistent with OGAC technical areas and results-based reporting expectations.
USAID indicates that the final Request for Applications (RFA) was planned for release in July or August 2009. In advance of that, USAID is specifically requesting feedback on the planned approaches described in the Concept Paper and on the anticipated higher-level results and outcomes. While USAID may consider the submitted input when finalizing the RFA, it also makes clear it is not obligated to incorporate all comments.
From a funding and award structure standpoint, USAID anticipates making one or more awards, with an expectation of two awards listed in the source data. The funding instrument type is a Cooperative Agreement, which typically means substantial involvement by USAID during implementation (for example, collaboration on planning, technical direction, or monitoring). The total planned funding for the activities over a three-year period is stated as approximately $40 million to $60 million, reflected as an award floor of $40,000,000 and an award ceiling of $60,000,000.
The opportunity is categorized as discretionary funding in the health sector (Funding Activity Category: Health) and is associated with CFDA 98.001 (USAID Foreign Assistance for Programs Overseas). Cost sharing or matching is required, meaning applicants should be prepared to contribute resources in addition to USAID funding, subject to the specific rules that would be set out in the final RFA.
Eligibility is listed as unrestricted (open to any type of entity), subject to any additional clarifications that would appear in the full announcement and later in the final RFA. The notice encourages firms, organizations, and other interested parties to review the Concept Paper, submit comments by the stated deadline, and consider preparing to compete once the final solicitation is issued.
Key administrative details include the funding opportunity number 611 2009 02 RFI MODIFICATION 01, with the comment period closing date shown as June 19, 2009, and an archive date of July 19, 2009. For issues accessing the full announcement electronically, the listed contact is Joseph Tembo, Acquisition Specialist at USAID/Zambia in Lusaka (phone +260 211 254303).
Frequently Asked Questions (FAQs)
1) Is this an active USAID funding opportunity I can apply to right now?
No. This posting is described as an informational notice from USAID/Zambia and explicitly states it is not an active Request for Applications (RFA). USAID is circulating a draft Concept Paper and requesting comments and suggestions to improve the final solicitation before it is released.
2) What is USAID asking organizations to do at this stage?
USAID is asking organizations and other interested parties to review the draft Concept Paper for the planned Community Based Prevention Initiative and submit comments and suggestions. USAID is specifically requesting feedback on the planned approaches and on the anticipated higher-level results and outcomes.
3) What is the planned program about?
The planned activity is a Community Based Prevention Initiative focused on orphans and vulnerable children (OVC), youth, and other vulnerable populations in Zambia. The notice frames it within U.S. Government global health priorities and HIV/AIDS-related prevention and vulnerability-reduction objectives.
4) Where will the planned activities take place?
The notice is issued by USAID/Zambia and describes a planned initiative focused on vulnerable populations in Zambia, indicating Zambia as the intended country context for implementation.
5) How is this planned program positioned within U.S. Government health priorities?
The notice states the program is explicitly guided by the Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008 and by technical guidance from the Office of the Global AIDS Coordinator (OGAC). This signals the eventual solicitation will likely align with PEPFAR-related prevention and vulnerability-reduction objectives and OGAC technical and results-based reporting expectations.
6) Does USAID have to incorporate the comments it receives?
No. USAID indicates it may consider submitted input when finalizing the RFA, but it also states it is not obligated to incorporate all comments.
7) When was the final Request for Applications (RFA) expected to be released?
USAID indicated the final RFA was planned for release in July or August 2009.
8) What is the deadline to submit comments on the Concept Paper?
The comment period closing date is shown as June 19, 2009.
9) What is the funding opportunity number for this notice?
The funding opportunity number listed is 611 2009 02 RFI MODIFICATION 01.
10) What is the archive date listed for this notice?
The archive date shown is July 19, 2009.
11) What type of funding instrument is anticipated for the eventual awards?
The anticipated funding instrument type is a Cooperative Agreement. The notice notes that this type of instrument typically involves substantial involvement by USAID during implementation (such as collaboration on planning, technical direction, or monitoring).
12) How many awards does USAID expect to make?
USAID anticipates making one or more awards. The source data also reflects an expectation of two awards.
13) What is the anticipated total funding amount and period of performance?
The total planned funding over a three-year period is stated as approximately $40 million to $60 million, reflected as an award floor of $40,000,000 and an award ceiling of $60,000,000.
14) What is the funding activity category and sector?
The opportunity is categorized as discretionary funding in the health sector, with Funding Activity Category listed as Health.
15) What CFDA number is associated with this opportunity?
The notice associates the opportunity with CFDA 98.001, described as USAID Foreign Assistance for Programs Overseas.
16) Is cost sharing or matching required?
Yes. The notice states that cost sharing or matching is required, meaning applicants should be prepared to contribute resources in addition to USAID funding, subject to specific rules that would be set out in the final RFA.
17) Who is eligible to participate (based on the notice)?
Eligibility is listed as unrestricted (open to any type of entity), subject to any additional clarifications that would appear in the full announcement and later in the final RFA.
18) What should interested organizations do to prepare for the eventual solicitation?
The notice encourages firms, organizations, and other interested parties to review the Concept Paper, submit comments by the stated deadline, and consider preparing to compete once the final solicitation is issued.
19) What kind of requirements should potential applicants anticipate due to OGAC/PEPFAR alignment?
Based on the notice framing, applicants should expect requirements consistent with OGAC technical areas and results-based reporting expectations, given the explicit linkage to the 2008 reauthorization act and OGAC technical guidance.
20) Who should I contact if I cannot access the full announcement electronically?
For issues accessing the full announcement electronically, the listed contact is Joseph Tembo, Acquisition Specialist at USAID/Zambia in Lusaka, phone +260 211 254303.
Browse more opportunities from the same category: Health
Next opportunity: Advanced Tools and Technologies for Cerebrospinal Fluid Shunts STTR (R41/R42)
Previous opportunity: Cognitive Neuroscience
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for 611 2009 02 RFI MODIFICATION 01
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (611 2009 02 RFI MODIFICATION 01) also looked into and applied for these:
| Funding Opportunity |
|---|
| 4 in 1 Title V HIV/AIDS Initiative Apply for HHS 2009 IHS UIHP 0003 Funding Number: HHS 2009 IHS UIHP 0003 Agency: Indian Health Service Category: Health Funding Amount: $30,000 |
| Cambodia Community Based HIV/AIDS Prevention and Care Program Apply for USAID CAMBODIA 442 09 004 RFA Funding Number: USAID CAMBODIA 442 09 004 RFA Agency: Cambodia USAID Phnom Penh Category: Health Funding Amount: $13,400,000 |
| NINDS Research Education Programs for Residents and Fellows in Neurology, Neurosurgery, Neuropathology and Neuroradiology (R25) Apply for RFA NS 10 002 Funding Number: RFA NS 10 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Congenital Conditions Apply for HRSA 09 256 Funding Number: HRSA 09 256 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| 2009 Request for Applications for the In Community Spirit Prevention of HIV/AIDS for Native/American Indian and Alaska Native Women Living in Rural1 and Frontier Indian Country Program Apply for WH HPP 09 001 Funding Number: WH HPP 09 001 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $100,000 |
| 2009 Request for Applications for the HIV/AIDS Prevention and Support Services for Women Partners of Incarcerated/Recently Released Men Apply for WH HPP 09 003 Funding Number: WH HPP 09 003 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $125,000 |
| 2009 The Institute for the Improvement of Minority Health and Health Disparities in the Delta Region Apply for MP CPI 09 001 Funding Number: MP CPI 09 001 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $5,283,000 |
| NHLBI Systems Biology Collaborations (R01) Apply for PAR 09 214 Funding Number: PAR 09 214 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| The Clearinghouse of Newborn Screening Information Apply for HRSA 09 257 Funding Number: HRSA 09 257 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| 2009 HIV Prevention for Women Living in the U.S. Virgin Islands. Apply for WH HPP 09 004 Funding Number: WH HPP 09 004 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $100,000 |
| PREDICT USAID Avian Pandemic Influenza and Zoonotic Disease Program Apply for USAID M OAA GH HSR 09 077 Funding Number: USAID M OAA GH HSR 09 077 Agency: Agency for International Development Category: Health Funding Amount: $75,000,000 |
| RESPOND USAID Avian Pandemic Influenza and Zoonotic Disease Program Apply for USAID M OAA GH HSR GH 09 878 Funding Number: USAID M OAA GH HSR GH 09 878 Agency: Agency for International Development Category: Health Funding Amount: $185,000,000 |
| B Cell Immunology Partnership Program For HIV 1 Vaccine Discovery (U19) Apply for RFA AI 09 022 Funding Number: RFA AI 09 022 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Community Prevention of Mother to Child Transmission (Community PMTCT) Apply for RFA 663 A 09 019 Funding Number: RFA 663 A 09 019 Agency: Ethiopia USAID Addis Ababa Category: Health Funding Amount: $30,000,000 |
| Targeted Issues in Traumatic Brain Injury Juvenile Justice and TBI Apply for HRSA 09 261 Funding Number: HRSA 09 261 Agency: Health Resources and Services Administration Category: Health Funding Amount: $250,000 |
| Sickle Cell Treatment Demonstration Program Apply for HRSA 09 231 Funding Number: HRSA 09 231 Agency: Health Resources and Services Administration Category: Health Funding Amount: $390,000 |
| 2009 Eliminating Disparities in Lupus through Education and Training for Health Professionals (EDLET/HP) Apply for MP MPC 09 009 Funding Number: MP MPC 09 009 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $1,600,000 |
| Identification and Characterization of Sensitive Periods for Neurodevelopment in Studies of Mental Illness (R01) Apply for RFA MH 10 010 Funding Number: RFA MH 10 010 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Identification and Characterization of Sensitive Periods for Neurodevelopment in Studies of Mental Illness (R21) Apply for RFA MH 10 011 Funding Number: RFA MH 10 011 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| HIV Prevention in Zambian Communities Apply for 611 2009 05 RFI MODIFICATION 01 Funding Number: 611 2009 05 RFI MODIFICATION 01 Agency: Zambia USAID Lusaka Category: Health Funding Amount: $2,500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "611 2009 02 RFI MODIFICATION 01", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.